FIGURE

Figure 2

ID

ZDB-FIG-230430-15

Publication

Aranda-Martínez et al., 2023 - Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment

Other Figures

All Figure Page

Back to All Figure Page

Figure 2

Endogenous levels of melatonin in zebrafish embryos during the day (light color) and during the night (dark color). Control, untreated embryos; aMT, control embryos treated with 1 μM melatonin; MPTP, embryos incubated with 600 μM MPTP; MPTP+MT₂, embryos treated with 600 μM MPTP from 24 hpf to 72 hpf plus 1 μM melatonin from 72 hpf to 120 hpf; MPTP+aMT₅, embryos treated with 600 μM MPTP from 24 hpf to 72 hpf plus 1 μM from 24 hpf to 120 hpf. Data are presented as mean ± SEM. * p < 0.05 vs. control; *** p < 0.001 vs. control, ### p < 0.001 vs. aMT; $$ p < 0.01 vs. MPTP; $$$ p < 0.001 vs. MPTP; δ p < 0.05 vs. day; δδ p < 0.01 vs. day; δδδ p < 0.001 vs. day. Unpaired t test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	AB
Conditions:	chemical treatment by environment: melatonin chemical treatment by environment: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine chemical treatment by environment: melatonin
Observed In:	whole organism melatonin
Stage:	Day 5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Antioxidants (Basel)